[1] Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI:a disease activity index for lupus patients.Arthritis Rheum,1992,35:630-640. [2] Jara LJ, Gomez-Sanchez C, Siverira LH,et al. Hyperprolactinemia in systemic lupus erythematosus:associaton with disease activity.Am J Med Sci,1992,303:222-226. [3] Alvarez-Nemegyei J, Cobarrubias-Cobos A, Escalante-Triay F, et al. Bromocriptine in systemic lupus erythematosus:a double-blind,randomized,placebo-controlled study.Lupus,1998,7:414-419. [4] Gutierrez MA, Molina JF, Jara LJ, et al. Prolactin-induced immunoglobulins and autoantibody production by peripheral blood mononuclear cells from systemic lupus erythematosus and normal individuals. Int Arch Allergy Immunol,1996,109:229-235. [5] Gala RR.Prolactin and growth hormone in the regulation of the immune system.Proc Soc Exp Biol Med,1991,198:513-527. [6] Leite De Moraes MC,Touraine P,Gagnerault MC,et al.Prolactin receptors and the immune system.Ann Endocrinol(Paris),1995,56:567-570. [7] Gaufo GO,Diamond MC.Prolactin increases CD4+/CD8+ cell ratio in thymus-grafted congenitally athymic nude mice.Proc Natl Acad Sci USA,1996,30:4165-4169. [8] Murphy WJ,Rui H,Longo DL.Effects of growth hormone and prolactin on immune development and function.Life Sci,1995,57:1-14. [9] Badolato R, Bond HM,Valerio G,et al.Differential expression of surface membrane growth hormone receptor on human peripheral blood lymphocytes detected by dual fluorochrome flow cytometry. J Clin Endocrinol Metab,1994,79:984-990. [10] Petersen BH,Rapaport R,Henry DP,et al. Effect of treatment with biosynthetic human growth hormone(GH) on peripheral blood lymphocyte populations and function in growth hormone-deficient children. J Clin Endocrinol Metab,1990,70:1756-1760. |